Xencor | XNCR - SCHULD





SCHULD Veränderung Datum
AbbVie USD 1000K 70.48B 2025-09
Alnylam Pharmaceuticals USD 1.31B 11.39M 2025-09
Amgen USD 54.59B 1.62B 2025-09
Arrowhead Research USD 366.28M 13.25M 2025-09
AstraZeneca USD 32.63B 207M 2025-09
Biogen USD 6.29B 1.7M 2025-12
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Cytokinetics USD 1.2B 338.79M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
J&J USD 45.8B 4.97B 2025-09
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
MacroGenics USD 37.01M 238K 2025-09
Merck USD 41.37B 5.97B 2025-09
Novartis USD 32.64B 1.37B 2025-06
Pfizer USD 60.85B 78M 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Roche Holding CHF 33.03B 1.41B 2025-06
Xencor USD 69.27M 1.34M 2025-09